Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1998-04-07
1999-03-16
Geist, Gary
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
562560, A01N 3710, C07C24100
Patent
active
058831304
ABSTRACT:
Crystalline N.sup.G -monomethyl-L-arginine hydrochloride is disclosed. At least three distinguishable isomorphic forms are present. The solid salt can be made by dissolving N.sup.G -monomethyl-L-arginine in hydrochloric acid and crystallising out N.sup.G -monomethyl-L-arginine hydrochloride. The crystallising step requires several months at low temperature. However, the process can be facilitated by seeding with crystals of N.sup.G -monomethyl-L-arginine hydrochloride. Alternatively, crystalline N.sup.G -monomethyl-L-arginine hydrochloride can be prepared by dissolving a salt of N.sup.G -monomethyl-L-arginine other than the hydrochloride salt with hydrochloric acid and removing the original salt forming ion by crystallising out the hydrochloride salt.
REFERENCES:
patent: 5225440 (1993-07-01), London
patent: 5374651 (1994-12-01), Kilbourn
Vogel "A Textbook of Practical Organic Chemistry" 3.sup.rd Ed., pp 122-136, 1956.
Kilbourn et al Proc. Natl. Acad. Sci. USA; vol. 87, pp. 3629-3632; May 1990 NG-Methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: Implications for the involvement of nitric oxide.
European Search Report PCT/GB93/01563.
Prabhakaran et al J.Am. Chem. Soc. 1988, 110, 5785-5791 Biosynthesis of Blasticidin S from L-.alpha.-Arginine etc.
546C88 for Septic Shock -Study termination Apr. 24, 1998 London.
Scrip Display Apr. 27, 1998 Glaxo Wellcome hits problems in sepsis.
Davis Brian J.
Geist Gary
Glaxo Wellcome Inc.
LandOfFree
Ng-monomethyl-l-arginine hydrochloride derivatives and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Ng-monomethyl-l-arginine hydrochloride derivatives and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ng-monomethyl-l-arginine hydrochloride derivatives and their use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-818127